On the Tank
Duvvuru Varshita and Vimal Kumar founded Vivalyf in Hyderabad in April 2021.
Also, Duvvura stated that she has cracked AIEEE, IIT-JEE, and NEET. She returned from IIT after 11 days.
Why started Vivalyf?
Duvura is Type 1 diabetic, i.e., from birth. She used to take insulin four to five times a day. She became frustrated with this routine and, at the age of 10, decided to find a solution, realizing that this was not just a problem for her but for many others as well.
As of now, our product is in the pre-clinical evaluation stage. To make this available in the market, we would require mentors, external connections, market access, and funding.
For this the launched, Easylife (glucometer device) is a non-invasive, no blood, no pain, and one-time investment device.
They achieved 90% accuracy by taking a total of 250 samples. Since then, they’ve been testing for just one month.
Therefore, as we take more and more samples, our goal is to increase the accuracy to 97%.
Shark Tank Recap
- Vivalyf sells Easylife (glucometer device) is a non-invasive, no blood, no pain, and one-time investment device.
- After the pre-clinical evaluation, they would move to clinical evaluation and would get 5000–6000 samples, which would help them in improving the efficiency, and would present that in front of “The Central Drug Standard Control Organization” (CDSCO).
- Ask: ₹56 lakhs in exchange for 7.5% equity making the valuation stand at ₹7.47 crores.
- At last, Together Peyush and Anupam would invest ₹56 lakhs in exchange for 33.33% equity, making the valuation stand at ₹1.68 crores.
Shark Tank Live
Ask
₹56 lakhs in exchange for 7.5% equity, making the valuation stand at ₹7.47 crores.
Earlier, raised ₹7.5 lakhs of grant from Govt. Of India under Nidhi Prayas Scheme.
Demo Review
Peyush- I am doubtful on its accuracy.
Sales and Revenue of Vivalyf
No sales as the business is in the pre-clinical evaluation stage.
Feedbacks from the sharks
- Namita(PharMaa) – I’m not interested in making any investments at this time. However, I can certainly assist you in establishing connections with hospitals for the purpose of sampling.
- Aman- I won’t be able to contribute.
- Ashneer- You lost me when you mentioned the accuracy standard.
Offer
Peyush and Anupam: Together for ₹56 lakhs in exchange for 33.33% equity making the valuation stand at ₹1.68 crores.
Counter offer
₹36 lakhs for 15% equity (valuation: ₹2.4 crores) and the remaining ₹20 lakhs in debt for 3 years.
Deal
Together Peyush and Anupam would come for ₹56 lakhs in exchange for 33.33% equity, making the valuation stand at ₹1.68 crores.ttis, pulvinar dapibus leo.
Vivalyf Beyond Tank tank updates
Beyond Tank constantly provide updates and follow-ups about the entrepreneurs from the day they appeared on Shark Tank India.